Active Filter(s):
Details:
Under the agreement, Kincell will manufacture Imugene’s Azer-cel (azercabtagene zapreleucel), an off-the-shelf (allogeneic) cell therapy CAR T drug, to support ongoing clinical trials.
Lead Product(s): Azercabtagene Zapreleucel,Cyclophosphamide,Fludarabine Phosphate
Therapeutic Area: Oncology Product Name: PBCAR0191
Highest Development Status: Phase I/ Phase II Product Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Imugene
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement April 16, 2024